ENTRY       D11261                      Drug
NAME        Marstacimab (USAN);
            Marstacimab (genetical recombination) (JAN)
FORMULA     C6304H9766N1678O2006S44
EXACT_MASS  142480.1473
MOL_WEIGHT  142567.8938
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSA ISGSGGSTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAILG ATSLSAFDIW GQGTMVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPEAAGA
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            QSVLTQPPSV SGAPGQRVTI SCTGSSSNIG AGYDVHWYQQ LPGTAPKLLI YGNSNRPSGV
            PDRFSGSKSG TSASLAITGL QAEDEADYYC QSYDSSLSGS GVFGGGTKLT VLGQPKAAPS
            VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP VKAGVETTTP SKQSNNKYAA
            SSYLSLTPEQ WKSHRSYSCQ VTHEGSTVEK TVAPTECS
            (Disulfide bridge: H22-H96, H147-H203, H223-L217, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'217, H'264-H'324, H'370-H'428, L22-L90, L140-L199, L'22-L'90, L'140-L'199)
  TYPE      Peptide
EFFICACY    Bleeding suppressant, Anti-tissue factor pathway inhibitor antibody
  TYPE      Monoclonal antibody
COMMENT     Preventing bleeding in patients with hemophilia
TARGET      TFPI [HSA:7035] [KO:K03909]
  PATHWAY   hsa04610(7035)  Complement and coagulation cascades
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                TFPI
                 D11261  Marstacimab (USAN)
DBLINKS     CAS: 1985638-39-8
            PubChem: 384585239
///
